References
- Durrani K, Kempen JH, Ying GS, et al. Adalimumab for ocular inflammation. Ocul Immunol Inflamm. 2016;22:1–8.
- Vallet H, Seve P, Biard L, et al. Infliximab versus adalimumab in the treatment of refractory inflammatory uveitis. Arthritis Rheum. 2016;68:1522–1530.
- Eb R, Me F, Maia M, et al. Therapeutic monoclonal antibodies in ophthalmology. Prog Retin Eye Res. 2009;28:117–144.
- Levy-Clarke G, D A J, R W R, et al. expert panel recommendations for the use of anti-tumor necrosis factor biologic agents in patients with ocular inflammatory disorders. Ophthalmology. 2014;121:785–796e3.